A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon's syndrome
M. Bodo et al., A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon's syndrome, EUR J CELL, 78(5), 1999, pp. 323-330
Bone development is controlled by the autocrine and/or paracrine effects of
regulatory molecules. We previously showed that the phenotype of fibroblas
ts obtained from patients affected by Crouzon's syndrome, an autosomal domi
nant disease characterized by pathological skull bone development, differed
from that of normal cells and was regulated by interleukin treatments. The
changes in the relative concentrations of extracellular macromolecules (gl
ycosaminoglycans-GAG, collagen and fibronectin) were associated with abnorm
al interleukin secretion that affected the microenvironment where the osteo
genic processes take place. Mutations in human fibroblast growth factor rec
eptors are now thought to be involved in Crouzon's syndrome. Since coactiva
tion of interleukins and basic fibroblast growth factor (bFGF) is probably
implicated in morphogenetic and osteogenic processes and heparan sulphate p
roteoglycans have a critical role in regulating bFGF activity, the phenotyp
es of normal and Crouzon osteoblasts were studied and the effects of bFGF o
n the expression of bFGF, procollagen alpha(1) (I), and proteoglycan (PG) g
enes for biglycan, decorin, betaglycan and syndecan analyzed. Specific huma
n cDNA probes were used to screen the relative levels of mRNA by Northern a
nalysis. Spontaneous or bFGF-modulated release of interleukins was also ass
ayed. The bFGF gene transcript was detected only in Crouzon osteoblasts. We
showed for the first time that Crouzon osteoblasts, despite a mutation in
the FGF receptor, still responded to exogenous bFGF. In fact, the growth fa
ctor induced changes in the GAG profile and in the levels of mRNA coding fo
r PG and procollagen alpha(1) (I) and down-regulated heparan sulfate GAG ch
ains. ELISA showed that bFGF-induced interleukin secretion differed in norm
al and Crouzon osteoblasts. The observed differences in PG core protein, pr
ocollagen alpha 1 (I) and bFGF could be associated with the Crouzon bone ph
enotype and also should provide further understanding on the molecular basi
s of the diseased state of bone.